Glucose Monitoring After Acute Myocardial Infarct in People With Diabetes
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 160 participants.
Also called NCT05431296
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 160 participants
- Sponsor
- Registry
-
NCT05431296
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United Kingdom
- Registry status
- Unknown status
Technical summary
Registry record NCT05431296. Randomized; no masking; primary purpose treatment. Start 2023-02-07 (actual); primary completion 2024-08 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Glucose Monitoring After Acute Myocardial Infarct in People With Diabetes
- Acronym
- GLAM
- Condition
- Type 2 Diabetes
- Condition
- Acute Myocardial Infarction
- Condition
- Acute Myocardial Infarction With ST Elevation
- Condition
- Diabetes Complications
- Intervention (Device)
- Dexcom ONE Continuous Glucose Monitoring System
- Lead sponsor
- Imperial College London
Record details
- Record id
cardio:ct-nct05431296- Content hash
c0b02dd932f1a477e4f40768a562703f2b08e6766a02f8518754a2aaecfc2a6e